Romania · Delayed Price · Currency is RON Med Life Statistics
Total Valuation
Med Life has a market cap or net worth of RON 6.10 billion. The enterprise value is 7.93 billion.
| Market Cap | 6.10B |
| Enterprise Value | 7.93B |
Important Dates
The last earnings date was Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Med Life has 530.82 million shares outstanding. The number of shares has decreased by -0.06% in one year.
| Current Share Class | 530.82M |
| Shares Outstanding | 530.82M |
| Shares Change (YoY) | -0.06% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 3.46% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 526.33 and the forward PE ratio is 52.27.
| PE Ratio | 526.33 |
| Forward PE | 52.27 |
| PS Ratio | 1.92 |
| PB Ratio | 10.94 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2,381.38 |
| P/OCF Ratio | 27.53 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.85, with an EV/FCF ratio of 3,095.21.
| EV / Earnings | 684.10 |
| EV / Sales | 2.50 |
| EV / EBITDA | 17.85 |
| EV / EBIT | 49.72 |
| EV / FCF | 3,095.21 |
Financial Position
The company has a current ratio of 0.79, with a Debt / Equity ratio of 3.46.
| Current Ratio | 0.79 |
| Quick Ratio | 0.54 |
| Debt / Equity | 3.46 |
| Debt / EBITDA | 4.34 |
| Debt / FCF | 753.17 |
| Interest Coverage | 1.79 |
Financial Efficiency
Return on equity (ROE) is -0.74% and return on invested capital (ROIC) is -1.46%.
| Return on Equity (ROE) | -0.74% |
| Return on Assets (ROA) | 3.18% |
| Return on Invested Capital (ROIC) | -1.46% |
| Return on Capital Employed (ROCE) | 6.72% |
| Weighted Average Cost of Capital (WACC) | 5.11% |
| Revenue Per Employee | 495,028 |
| Profits Per Employee | 1,809 |
| Employee Count | 6,638 |
| Asset Turnover | 1.01 |
| Inventory Turnover | 10.80 |
Taxes
In the past 12 months, Med Life has paid 23.11 million in taxes.
| Income Tax | 23.11M |
| Effective Tax Rate | 120.61% |
Stock Price Statistics
The stock price has increased by +91.85% in the last 52 weeks. The beta is 0.50, so Med Life's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | +91.85% |
| 50-Day Moving Average | 12.60 |
| 200-Day Moving Average | 9.11 |
| Relative Strength Index (RSI) | 39.34 |
| Average Volume (20 Days) | 169,861 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Med Life had revenue of RON 3.17 billion and earned 11.60 million in profits. Earnings per share was 0.02.
| Revenue | 3.17B |
| Gross Profit | 1.54B |
| Operating Income | 159.58M |
| Pretax Income | 19.16M |
| Net Income | 11.60M |
| EBITDA | 444.48M |
| EBIT | 159.58M |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 175.25 million in cash and 1.93 billion in debt, with a net cash position of -1.76 billion or -3.31 per share.
| Cash & Cash Equivalents | 175.25M |
| Total Debt | 1.93B |
| Net Cash | -1.76B |
| Net Cash Per Share | -3.31 |
| Equity (Book Value) | 558.19M |
| Book Value Per Share | 0.91 |
| Working Capital | -187.90M |
Cash Flow
In the last 12 months, operating cash flow was 221.73 million and capital expenditures -219.16 million, giving a free cash flow of 2.56 million.
| Operating Cash Flow | 221.73M |
| Capital Expenditures | -219.16M |
| Free Cash Flow | 2.56M |
| FCF Per Share | 0.00 |
Margins
Gross margin is 48.60%, with operating and profit margins of 5.03% and 0.37%.
| Gross Margin | 48.60% |
| Operating Margin | 5.03% |
| Pretax Margin | 0.60% |
| Profit Margin | 0.37% |
| EBITDA Margin | 14.00% |
| EBIT Margin | 5.03% |
| FCF Margin | 0.08% |
Dividends & Yields
Med Life does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.06% |
| Shareholder Yield | 0.06% |
| Earnings Yield | 0.19% |
| FCF Yield | 0.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 1, 2023. It was a forward split with a ratio of 4.
| Last Split Date | Sep 1, 2023 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Med Life has an Altman Z-Score of 1.94 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.94 |
| Piotroski F-Score | 6 |